Skip to Content
  • MyChart

    Log in to our secure, personalized website to manage your care (formerly myMDAnderson).

  • Request an Appointment

    If you are ready to make an appointment, select a button on the right. If you have questions about UT MD Anderson’s appointment process, our information page may be the best place to start.

    Appointment Information
    New Patients Current Patients Referring Physicians
  • Every Breakthrough
    Begins With You

    Gifts to UT MD Anderson’s historic philanthropic campaign help accelerate discovery, transform lives and bring hope to more patients than ever before.

    Learn more about Only Possible Here
    Donate Today only-possible-here-logo
The University of Texas MD Anderson Cancer Center
  • Clinical Trials
  • Locations
  • Careers
  • Contact Us
  • Our Doctors
    • Español
    • عربى
    • 中文
    • Türkçe
Clear
close
      MyChart
      Donate Today
      • Clinical Trials
      • Locations
      • Careers
      • Contact Us
        • Español
        • عربى
        • 中文
        • Türkçe
      • Request an Appointment
      • New Patients
      • Current Patients
      • Referring Physicians
      • Patients & Family
          • Becoming Our Patient Home
          • Why UT MD Anderson
          • Planning for Care
          • Getting to UT MD Anderson
          • While You're Here
          • International Center
          • Services and Amenities
          • Insurance & Billing
          • Second Opinion Appointments
          • Diagnosis & Treatment Home
          • Cancer Types
          • A New Diagnosis
          • Treatment Options
          • Care Centers & Clinics
          • Emotional & Physical Effects
          • Patient Support
          • Clinical Trials
          • Supporting a Loved One Home
          • Caregiver Roles & Challenges
          • Children and Teens
          • Taking Care of Yourself
          • Helping a UT MD Anderson Patient
          • Dealing with Loss
          • Life After Cancer Home
          • Follow-up Care After Cancer Treatment
          • Long-Term Effects of Cancer
          • Social & Emotional Impacts of Cancer
          • Legal & Financial Impacts of Cancer
          • Survivorship Week
        • Request an Appointment Current Patients

          Find information and resources for current and returning patients.

          Clinical Trials

          Learn about clinical trials at UT MD Anderson and search our database for open studies.

      • Prevention & Screening
          • Manage Your Risk Home
          • Tobacco Control
          • Diet
          • Body Weight
          • Physical Activity
          • Skin Safety
          • HPV
          • Hepatitis
          • Alcohol
          • Family History Home
          • Genetic Testing
          • Hereditary Cancer Syndromes
          • Genetic Counseling and Testing FAQs
          • Cancer Screenings Home
          • Mammograms & Breast Cancer Screening
          • Cervical Cancer Screening
          • Colorectal Cancer Screening
          • Endometrial Cancer Screening
          • Liver Cancer Screening
          • Lung Cancer Screening
          • Mobile Mammography
          • Ovarian Cancer Screening
          • Prostate Cancer Screening
          • Skin Cancer Screening
          • Women's Cancer Screening
          • Men's Cancer Screening
        • Cancer Prevention Center 

          The Lyda Hill Cancer Prevention Center provides cancer risk assessment, screening and diagnostic services.

      • Donors & Volunteers
          • Donate Home
          • Raise Money
          • Honor Loved Ones
          • Create Your Legacy
          • Endowments
          • Caring Fund
          • Matching Gifts
          • Foundation and Corporation Relations
          • Volunteer Home
          • Why Volunteer
          • On-Site Volunteers
          • Volunteer Endowment
          • Patient Experience
          • Teen Volunteer Leadership Program
          • Children's Cancer Hospital Councils
          • Other Ways to Help Home
          • Give Blood
          • Shop UT MD Anderson
          • Children's Art Project
          • Donate Goods or Services
          • Attend Events
          • Cord Blood Bank
          • Corporate Alliances Home
          • Current Alliances
        • Join the Campaign to End Cancer 

          Help us celebrate and fuel the groundbreaking innovations and transformative advancements that define UT MD Anderson.

      • For Physicians
          • Refer a Patient Home
          • Health Care Provider Resource Center
          • Referring Provider Team
          • Insurance Information
          • International Referrals
          • myMDAnderson for Physicians
          • Second Opinion Pathology
          • Clinical Trials Home
          • Clinical Tools & Resources Home
          • Clinical Calculators
          • Clinical Practice Algorithms
        • myMDAnderson for Physicians 

          Our personalized portal helps you refer your patients and communicate with their UT MD Anderson care team.

      • Research
          • Departments, Labs and Institutes Home
          • Departments and Divisions
          • Labs
          • Research Centers and Programs
          • Institutes
          • Specialized Programs of Research Excellence (SPORE) Grants
          • Research Areas Home
          • Basic Science
          • Translational Research
          • Clinical Research
          • Prevention & Personalized Risk Assessment
          • Research Resources Home
          • Excellence in Science
          • Core Facilities and Services
          • Conferences & Seminars
          • Why Research at UT MD Anderson
          • STRIDE
          • NCI-Designated Cancer Center
          • Data Resources
        • Clinical Trials 

          As part of our mission to eliminate cancer, UT MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers.

      • Education & Training
          • Degree-Granting Schools Home
          • School of Health Professions
          • MD Anderson UTHealth Houston Graduate School
          • Research Training Home
          • Early Career Pathway Programs
          • Predoctoral Training
          • Postdoctoral Training
          • Mentored Faculty Programs
          • Career Development
          • Clinical Training Home
          • Graduate Medical Education
          • Clinical Education for Non-Physicians
          • Nursing Education & Training
          • Continuing Education & Review Courses
          • Simulation Center
          • Continuing Education & Professional Development Home
          • Continuing Professional Education/Conferences
          • Administrative Internships & Fellowships
          • Cancer Survivorship Professional Education
          • Leadership Institute
          • Patient Home Visits
          • Education Resources Home
          • Alumni Relations
          • Education Design Services
          • Awards & Recognitions
          • Academic Mentoring Council
          • Why UT MD Anderson & Houston
          • Outreach Programs Home
          • Project ECHO
          • Observer Programs
          • Comparative Effectiveness Training (CERTaIN)
          • Faculty Speakers Bureau
        • Apply to SHP

          Choose from 12 allied health programs at School of Health Professions.

          Research Trainees

          View open postdoctoral and other research trainee positions.

          GME Fellowships

          Learn about our graduate medical education residency and fellowship opportunities.

      Joanne Becker Image

      Joanne Lynn Becker, MD

      Department of Laboratory Medicine, Division of Pathology-Lab Medicine Div

      In the News

      Illustration of red blood cells flowing through a blood vessel

      12 things to know about donating platelets

      Present Title & Affiliation

      Primary Appointment

      Professor, Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas

      Dual/Joint/Adjunct Appointment

      Voluntary Clinical Professor in the Department of Clinical Sciences, University of Houston Tilman J Feritta Familly College of Medicine, Houston, Texas

      Professor of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas

      Education & Training

      Degree-Granting Education

      1989Northeaster Ohio Medical University College of Medicine, Rootstown, OH, US, MD
      1983General Science, Youngstown State University, Youngstown, OH, US, BS

      Postgraduate Training

      1994-1995Clinical Fellowship, Fellowship, Blood Banking and Transfusion Medicine University of Pennsylvania, Philadelphia, PA
      1989-1994Clinical Residency, Department of Anatomic and Clinical Pathology SUNY Stony Brook Medicine, Stony Brook, NY

      Licenses & Certifications

      2025Texas, Medical License V6261
      1996American Board of Pathology, Blood Banking and Transfusion Medicine
      1995Virginia, Medical License 52537
      1995DEA Registration BB4609965
      1994American Board of Pathology, Anatomic and Clinical Pathology
      1994New York, Medical License 194831

      Experience & Service

      Faculty Academic Appointments

      Associate Professor of Oncology, Roswell Park Comprehensive Cancer Center, 2005 - 2025

      Clinical Assistant Professor, Department of Pathology and Anatomic Science Jacobs School of Medicine and Biomedical Sciences SUNY University at Buffalo, Buffalo, NY, 1999 - 2025

      Assistant Professor of Oncology, Roswell Park Cancer Institute, 1999 - 2005

      Assistant Professor, Department of Pathology Medical College of Virginia Campus of VCU, Richmond, VA, 1995 - 1999

      Assistant Instructor, Department of Pathology and Laboratory Medicine University of Pennsylvania School of Medicine, Philadelphia, PA, 1994 - 1995

      Assistant Clinical Instructor, Department of Pathology SUNY Stony Brook, Stony Brook, NY, 1989 - 1994

      Adjunct Instructor, Department of Chemistry Youngstown State University, Youngstown, OH, 1983 - 1984

      Administrative Appointments/Responsibilities

      Medical Director, Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2025 - Present

      Vice Chair, Department of Pathology and Laboratory Medicine Roswell Park Comprehensive Cancer Center, Buffalo, NY, 2021 - 2025

      Medical Director, Upgrade NY Transplant Services DBA Connect Life, New York, 2005 - 2025

      Chief, Department of Laboratory Medicine Roswell Park Comprehensive Cancer Center, Buffalo, NY, 2005 - 2025

      Interim Director, Laboratory Medicine Roswell Park Comprehensive Cancer Center, Buffalo, NY, 2003 - 2025

      Director, Blood Services Kaleida Health, Buffalo, NY, 2000 - 2002

      Medical Director, Therapeutic Apheresis Roswell Park Comprehensive Cancer Center, Buffalo, NY, 2000 - 2025

      Laboratory Director, Stem Cell Laboratory Roswell Park Comprehensive Cancer Center, Buffalo, NY, 2000 - 2025

      Medical Director, Blood Bank Roswell Park Comprehensive Cancer Center, Buffalo, NY, 1999 - 2025

      Assistant Director, Laboratory Medicine Roswell Park Comprehensive Cancer Center, Buffalo, NY, 1999 - 2023

      Director Blood Bank, Medical College of Virginia Hospitals of VCU, Richmond, VA, 1996 - 1999

      Associate Director, Blood Bank Medical College of Virginia Hospitals of VCU, Richmond, VA, 1995 - 1996

      Other Professional Positions

      Attending Physician, Roswell Park Comprehensive Cancer Center, 2007 - 2025

      Extramural Institutional Committee Activities

      Member, Transfusion Committee, The University of Texas MD Anderson Cancer Center, 2025 - Present

      Member, Board of Directors, Kidney Foundation of WNY, 2020 - Present

      Member, Board of Directors, Connect Life (local eye, organ, tissue and blood donation organization, 2020 - 2024

      Member, AABB Annual Meeting Program Committee, Association for the Advancement of Blood & Biotherapies, 2019 - 2023

      Member, FEMA for Transfusion, Steering Committee, Roswell Park Comprehensive Cancer Center, 2019 - 2022

      Member, ASFA Physicians Committee, American Society for Apheresis, 2017 - Present

      Member, ASFA Apheresis Medicine Attending Physicians Subcommittee, American Society for Apheresis, 2017 - Present

      Member, Laboratory Utilization Committee, Roswell Park Comprehensive Cancer Center, 2014 - 2023

      Member, AABB representative to CAP Transfusion and Cellular Therapy Committee, Association for the Advancement of Blood & Biotherapies, 2013 - Present

      Member, AABB Board of Directors, Association for the Advancement of Blood & Biotherapies, 2011 - 2013

      Member, AABB RBC Guidelines Group, Association for the Advancement of Blood & Biotherapies, 2010 - 2011

      Member, Institutional Biosafety Committee, Roswell Park Comprehensive Cancer Center, 2006 - 2025

      Member, Critical Care Committee, Roswell Park Comprehensive Cancer Center, 2006 - 2022

      Member, AABB Clinical Transfusion Medicine Committee, Association for the Advancement of Blood & Biotherapies, 2006 - 2010

      Member, Dialysis QA Committee, Roswell Park Comprehensive Cancer Center, 2006 - 2008

      Member, BBANYS President, Blood Banks Association of New York State, 2005 - 2007

      Member, AABB Immunohematology Standards Committee, Association for the Advancement of Blood & Biotherapies, 2003 - 2011

      Member, BBANYS Strategic Planning Committee, Blood Banks Association of New York State, 2003 - 2009

      Member, AABB Annual Meeting Program Committee, Association for the Advancement of Blood & Biotherapies, 2003 - 2007

      Member, CPOE/EMR Evaluation Committee, Roswell Park Comprehensive Cancer Center, 2003 - 2004

      Member, BBANYS Annual Meeting Committee Chair, Blood Banks Association of New York State, 2002 - Present

      Member, AABB Standards program subcommittee on Quality Management, Association for the Advancement of Blood & Biotherapies, 2002 - 2010

      Member, BBANYS Education Committee Chair, Blood Banks Association of New York State, 2002 - 2003

      Member, Medical Staff Executive Committee, Roswell Park Comprehensive Cancer Center, 2001 - 2004

      Member, BBANYS Membership Committee Chair, Blood Banks Association of New York State, 2001 - 2002

      Member, Transfusion Committee, Roswell Park Comprehensive Cancer Center, 2000 - Present

      Member, Transplant and Cellular Therapy Quality Improvement, Roswell Park Comprehensive Cancer Center, 2000 - 2024

      Member, Institutional Quality Improvement, Roswell Park Comprehensive Cancer Center, 2000 - 2019

      Member, BBANYS Board of Directors, Blood Banks Association of New York State, 2000 - 2009

      Member, Health Information/Medical Records, Roswell Park Comprehensive Cancer Center, 2000 - 2004

      Member, Transfusion Committee, Kaleida Health, 2000 - 2002

      Chair, HCV Lookback, Medical College of Virginia Hospital, Virginia Commonwealth University, 1998 - 1999

      Member, MAABB Education Committee, Mid Atlantic Association of Blood Banks, 1997 - 1999

      Member, Residency Committee, Medical College of Virginia Hospital, Virginia Commonwealth University, 1997 - 1999

      Member, Blood Utilization Committee, Medical College of Virginia Hospital, Virginia Commonwealth University, 1995 - 1999

      Member, Operating Room Committee, Medical College of Virginia Hospital, Virginia Commonwealth University, 1995 - 1999

      Editorial Activities

      Member, NYS Council on Human Blood and Transfusion Services, 2024 - Present

      Member, FDA Blood Products Advisory Committee, 2012 - Present

      Honors & Awards

      2017AABB Top Abstract Award
      2013AABB Best Poster Award
      1993CAP Foundation Scholar
      1992Pathology Resident Award CAP/ASCP, Best Paper Presentation, Spring meeting
      1992Pathology Resident Award CAP/ASCP, Best Paper Presentation, Fall meeting
      1991Gordon F. Vawter Award, Society for Pediatric Pathology

      Professional Memberships

      International Society for Cellular Therapy

      2000 - Present

      Blood Bank Association of New York State

      2000 - Present

      American Society for Apheresis

      1996 - Present

      American Society of Hematology

      1996 - Present

      Association for the Advancement of Blood And Biotherapies

      1995 - Present

      Mid Atlantic Association of Blood Banks

      1995 - 1999

      American Society of Clinical Pathologists

      1991 - Present

      College of American Pathologists

      1991 - Present

      Selected Presentations & Talks

      Local Presentations

      1. 2021. PAS Platelets BBANYS Annual Meeting, US.
      2. 2020. Because it is all about the patient: ASFA webinar, US.
      3. 2019. The Platelet Cafe, Michigan Society of Blood Banks, US.
      4. 2019. Apheresis Basics, Clinical Research Services Education Day RPCCC, US.
      5. 2018. Any Problem Can Teach, AABB Annual Meeting, US.
      6. 2017. Platelets, Pathology Rounds, Department of Pathology, University of Chicago, US.
      7. 2017. Semi-Automating the Whole Blood Exchange – Session on whole blood exchange in autoimmune hemolytic anemia AABB, US.
      8. 2016. Platelets: Now available in 38 Flavors, Pathology Grand Rounds, Department of Pathology, Thomas Jefferson University School of Medicine, US.
      9. 2016. Platelets: Now available in 38 flavors. Harold Oberman Lecture University of Michigan, US.
      10. 2015. Cerus Educational Session at AABB Pathogen Inactivation, the Hospital Perspective, US.
      11. 2014. Terumo Educational Session at AABB Using PAS in Practice, US.
      12. 2013. Fenwal Educational session at AABB Blood Management in Apheresis: MNC collection using the Fenwal Amicus, US.
      13. 2013. Fenwal Educational session at AABB PAS Platelets, US.
      14. 2013. Fenwal Educational session at ASFA, platelet sparing in MNC collection, US.
      15. 2012. First experiences with PAS. America’s Blood Centers Spring Meeting, US.
      16. 2011. Because it is all about the Patient. BCA Breakfast, US.
      17. 2011. Current Issues in Transfusion Medicine: Grand Rounds, WCA Hospital, US.
      18. 2010. Transfusion Reactions – CLMA Regional meeting, US.
      19. 2009. Transfusion Reactions – retrospective of institutional and state reporting. Visiting Professor, University of North Carolina, US.
      20. 2009. Photopheresis, Annual Meeting, Blood Bank Association of New York State, US.
      21. 2009. Blood Transfusion in the 21st century. Grand Rounds Eastern Niagara Medical Center Lockport Hospital Staff, US.
      22. 2008. MNC collections using the Fenwal Amicus; Fenwal Educational Session, ASFA, US.
      23. 2007. Transfusion Medicine Update. RPCI Training Lecture Series, US.
      24. 2007. Transfusion Medicine Update. RPCI Training Lecture Series, US.
      25. 2006. Stem Cell Transplant from the Laboratory Perspective, Visiting Professor, William Beaumont Hospital, Royal Oak, MI, US.
      26. 2006. Update in Transfusion medicine, Grand Rounds, WCA Hospital, Jamestown, NY, US.
      27. 2006. TRALI – a case report and review of the literature, Grand Rounds, Children’s Hospital of Buffalo, US.
      28. 2006. Update in Transfusion Medicine, Grand Rounds, Sister’s Hospital, Buffalo, NY, US.
      29. 2003. Automated Hematology Analyzers in the Blood Bank, AACC companion meeting sponsored by Bayer, US.
      30. 2002. Special Products for Special Patients, Regional FDA, US.
      31. 2002. Moderator – Scientific Abstracts ASH, US.
      32. 2002. Six Sigma, University of Texas Health Science Center at San Antonio Teleconference Network of Texas, US.
      33. 2002. Six Sigma Quality Concepts, American Association of Blood Banks, US.
      34. 2002. Making the cGMP’s work for you Blood Bank Association of New York State, US.
      35. 2002. Stem Cell Processing and Testing, University of Texas Health Science Center at San Antonio Teleconference Network of Texas, US.
      36. 2002. Moderator – Clinical Abstracts ASFA, US.
      37. 2002. Six Sigma- What’s the Big Deal? Mid Atlantic Association of Blood Banks, US.
      38. 2002. Stem Cell Processing and Testing, Blood Bank Supervisors Association of New York City, US.
      39. 2001. Moderator – Clinical Abstracts ASFA, US.
      40. 2000. Hemoglobin Oxygen Carriers, Ex Vivo Expansion, and Growth Factors, ADRP program at American Association of Blood Banks, US.
      41. 1999. Hemoglobin Oxygen Carriers, Ex Vivo Expansion, and Growth Factors, ADRP program at American Association of Blood Banks, US.
      42. 1999. Update in Pediatric Transfusion Therapy, Grand Rounds – Department of Pediatrics, Medical College of Virginia Hospital, US.
      43. 1999. Six Sigma Error Management Systems, Society for Health Systems of the Institute of Industrial Engineers, US.
      44. 1999. Laboratory Error Management, Clinical Lab Management Association, US.
      45. 1999. Emerging Technology and its Impact on Donor Recruitment, Association of Donor Recruitment Professionals, US.
      46. 1999. Red Cell Transfusion in Transplant Patients, Mid Atlantic Association of Blood Banks, US.
      47. 1999. Plasma-Now available in 31 Flavors… Mid Atlantic Association of Blood Banks, US.
      48. 1998. Laboratory Error Management, Society for Health Systems of the Institute of Industrial Engineers, US.
      49. 1998. Stem Cell Collection and Transplantation. Virginia Society for Pathology Spring Seminar, US.
      50. 1998. Hemolytic Pathophysiology. Technical Workshop on Consequences of Transfusion Therapy. Mid Atlantic Association of Blood Banks, US.
      51. 1997. Massive Transfusions. Grand Rounds – Department of Anesthesiology, Medical College of Virginia Hospital, US.
      52. 1997. Transfusion Guidelines – Grand Rounds – Department of Surgery, Medical College of Virginia Hospital, US.
      53. 1997. Autologous Blood Use: Continuing Education Seminar Williamsburg Community Hospital, US.
      54. 1997. Treatment of TTP: have we progressed beyond “barber” medicine. Department of Pathology State University of New York, Health Sciences Center at Syracuse, US.
      55. 1996. Cord Blood Transplants: Grand Rounds – Department of Neonatal Medicine, Medical College of Virginia Hospital, US.
      56. 1996. Update in Transfusion Medicine: Continuing Education Seminar Danville Regional Medical Center, US.
      57. 1996. In situ PCR techniques: Perkin Elmer Symposium on In Situ PCR, US.

      Formal Peers

      1. 2017. Weekly CP Case Conference with UB Department of Pathology Residents, US.
      2. 2015. 2-hour Boot Camp lecture for Heme/Onc fellows covering basics for transfusion, reactions, and therapeutic apheresis, US.
      3. 2000. Heme/Onc Fellows hosting 2-week Transfusion Medicine rotations (7 fellows/year), US.
      Read More
      Less

      Grant & Contract Support

      Date: 2016 - 2019
      Title:Evaluation of transfusion reactions in patients receiving additive solution platelets
      Funding Source:Terumo
      Role:PI
      Date: 1993 - 1994
      Title:Detection of HIV and EBV in AIDS Related Lymphomas by in-situ PCR
      Funding Source:CAP Foundation
      Role:PI

      Selected Publications

      Peer-Reviewed Articles

      1. Wheeler AP, Snyder EL, Refaai M, Cohn CS, Poisson J, Fontaine M, Sehl M, Nooka AK, Uhl L, Spinella PC, Fenelus M, Liles D, Coyle T, Becker J, Jeng M, Gehrie EA, Spencer BR, Young P, Johnson A, O'Brien JJ, Schiller GJ, Roback JD, Malynn E, Jackups R, Avecilla ST, Liu K, Bentow S, Varrone J, Benjamin RJ, Corash LM. Acute pulmonary injury in hematology patients supported with pathogen-reduced and conventional platelet components. Blood Adv 8(9):2290-2299, 2024. e-Pub 2024. PMID: 38447116.
      2. Gammon R, Becker J, Cameron T, Eichbaum Q, Jindal A, Lamba DS, Nalezinski S, Rios J, Shaikh S, Shepherd J, Tanhehco YC. How do I manage a blood product shortage?. Transfusion 63(12):2205-2213, 2023. e-Pub 2023. PMID: 37840217.
      3. Snyder EL, Wheeler AP, Refaai M, Cohn CS, Poisson J, Fontaine M, Sehl M, Nooka AK, Uhl L, Spinella P, Fenelus M, Liles D, Coyle T, Becker J, Jeng M, Gehrie EA, Spencer BR, Young P, Johnson A, O'Brien JJ, Schiller GJ, Roback JD, Malynn E, Jackups R, Avecilla ST, Lin JS, Liu K, Bentow S, Peng HL, Varrone J, Benjamin RJ, Corash LM. Comparative risk of pulmonary adverse events with transfusion of pathogen reduced and conventional platelet components. Transfusion 62(7):1365-1376, 2022. e-Pub 2022. PMID: 35748490.
      4. Karafin MS, Becker JL, Berg M, DeSimone RA, Draper NL, Hudgins J, Metcalf RA, Pagano MB, Park YA, Rossmann SN, Schwartz J, Souers R, Thomas L, Uhl L, Ramsey GE. Heterogeneity in Approaches for Switching From Universal to Patient ABO Type-Specific Blood Components During Massive Hemorrhage. Arch Pathol Lab Med 145(12):1499-1504, 2021. e-Pub 2021. PMID: 33720316.
      5. Tanhehco YC, Li Y, Zantek ND, Becker J, Alsammak M, Mikesell K, Wu DW, Foster T, Chhibber V, Martin MS, Wehrli G. Apheresis physician well-being during the COVID-19 pandemic: Results of a survey. Transfusion 61(5):1542-1550, 2021. e-Pub 2021. PMID: 33619750.
      6. Lin DM, Becker J, Wu Y, Cooling L. How do I perform whole blood exchange?. Transfusion 60(3):449-453, 2020. e-Pub 2020. PMID: 31909491.
      7. Tanhehco YC, Zantek ND, Alsammak M, Chhibber V, Li Y, Becker J, Wu DW, Foster T, Wehrli G. Vascular access practices for therapeutic apheresis: Results of a survey. J Clin Apher 34(5):571-578, 2019. e-Pub 2019. PMID: 31268582.
      8. Patel PP, Becker J, Freyer C, Griffiths E, Thompson JE, Wang ES. Rituximab-refractory thrombotic thrombocytopenic purpura responsive to intravenous but not subcutaneous bortezomib. Transfusion 56(4):970-4, 2016. e-Pub 2016. PMID: 26779871.
      9. Bharthuar A, Egloff L, Becker J, George M, Lohr JW, Deeb G, Iyer RV. Rituximab-based therapy for gemcitabine-induced hemolytic uremic syndrome in a patient with metastatic pancreatic adenocarcinoma: a case report. Cancer Chemother Pharmacol 64(1):177-81, 2009. e-Pub 2009. PMID: 19116715.
      10. Battiwalla M, Paplham P, Almyroudis NG, McCarthy A, Abdelhalim A, Elefante A, Smith P, Becker J, McCarthy PL, Segal BH. Leflunomide failure to control recurrent cytomegalovirus infection in the setting of renal failure after allogeneic stem cell transplantation. Transpl Infect Dis 9(1):28-32, 2007. e-Pub 2007. PMID: 17313468.
      11. Battiwalla M, Hahn T, Radovic M, Roy H, Wahab A, Duman E, Bajwa R, Padmanabhan S, Becker J, Barrett AJ, McCarthy PL Jr. Human leukocyte antigen (HLA) DR15 is associated with reduced incidence of acute GVHD in HLA-matched allogeneic transplantation but does not impact chronic GVHD incidence. Blood 107(5):1970-3, 2006. e-Pub 2006. PMID: 16282347.
      12. Hahn T, Benekli M, Wong C, Moysich KB, Hyland A, Michalek AM, Alam A, Baer MR, Bambach B, Czuczman MS, Wetzler M, Becker JL, McCarthy PL. A prognostic model for prolonged event-free survival after autologous or allogeneic blood or marrow transplantation for relapsed and refractory Hodgkin's disease. Bone Marrow Transplant 35(6):557-66, 2005. e-Pub 2005. PMID: 15665852.
      13. Hahn T, Alam AR, Lawrence D, Ford L, Baer MR, Bambach B, Bernstein ZP, Czuczman MS, Silva J, Slack JL, Wetzler M, Becker J, McCarthy PL Jr. Thrombotic microangiopathy after allogeneic blood and marrow transplantation is associated with dose-intensive myeloablative conditioning regimens, unrelated donor, and methylprednisolone T-cell depletion. Transplantation 78(10):1515-22, 2004. e-Pub 2004. PMID: 15599317.
      14. Shieh S, Fang YV, Becker JL, Holm A, Beutner EH, Helm TN. Pemphigus, pregnancy, and plasmapheresis. Cutis 73(5):327-9, 2004. e-Pub 2004. PMID: 15186047.
      15. Aune MW, Becker JL, Brugnara C, Canfield W, Dorfman DM, Fiehn W, Fischer G, Fitzpatrick P, Flaming TH, Henriksen HK, Kunicka JE, Lackner KJ, Minchello E, Mullenix PA, Myers M, Petersen A, Ternstrom W, Wilson SJ. Automated flow cytometric analysis of blood cells in cerebrospinal fluid: analytic performance. Am J Clin Pathol 121(5):690-700, 2004. e-Pub 2004. PMID: 15151209.
      16. Hahn T, Bunworasate U, George MC, Bir AS, Chinratanalab W, Alam AR, Bambach B, Baer MR, Slack JL, Wetzler M, Becker JL, McCarthy PL Jr. Use of nonvolume-reduced (unmanipulated after thawing) umbilical cord blood stem cells for allogeneic transplantation results in safe engraftment. Bone Marrow Transplant 32(2):145-50, 2003. e-Pub 2003. PMID: 12838278.
      17. Benekli M, Hahn T, Shafi F, Qureshi A, Alam AR, Czuczman MS, Bernstein ZP, Chanan-Khan AA, Becker JL, McCarthy PL. Effect of rituximab on peripheral blood stem cell mobilization and engraftment kinetics in non-Hodgkin's lymphoma patients. Bone Marrow Transplant 32(2):139-43, 2003. e-Pub 2003. PMID: 12838277.
      18. Ahmad I, Islam T, Chanan-Khan A, Hahn T, Wentling D, Becker JL, McCarthy PL Jr, Alam AR. Thalidomide as salvage therapy for VAD-refractory multiple myeloma prior to autologous PBSCT. Bone Marrow Transplant 29(7):577-80, 2002. e-Pub 2002. PMID: 11979306.
      19. Becker JL, Miller F, Nuovo GJ, Josepovitz C, Schubach WH, Nord EP. Epstein-Barr virus infection of renal proximal tubule cells: possible role in chronic interstitial nephritis. J Clin Invest 104(12):1673-81, 1999. e-Pub 1999. PMID: 10606621.
      20. Becker JL, Steigbigel RT, Nuovo GJ. In situ detection of PCR-amplified HIV-1 and EBV nucleic acids in hyperplastic lymph nodes and in AIDS-related lymphoma. J Histochem Cytochem 44(10):1085-9, 1996. e-Pub 1996. PMID: 8813072.
      21. Nuovo GJ, Becker J, Burk MW, Margiotta M, Fuhrer J, Steigbigel RT. In situ detection of PCR-amplified HIV-1 nucleic acids in lymph nodes and peripheral blood in patients with asymptomatic HIV-1 infection and advanced-stage AIDS. J Acquir Immune Defic Syndr (1988) 7(9):916-23, 1994. e-Pub 1994. PMID: 7914231.
      22. Nuovo GJ, Becker J, Simsir A, Margiotta M, Khalife G, Shevchuk M. HIV-1 nucleic acids localize to the spermatogonia and their progeny. A study by polymerase chain reaction in situ hybridization. Am J Pathol 144(6):1142-8, 1994. e-Pub 1994. PMID: 8203455.
      23. Nuovo MA, Nuovo GJ, Becker J, Gallery F, Delvenne P, Kane PB. Correlation of viral infection, histology, and mortality in immunocompromised patients with pneumonia. Analysis by in situ hybridization and the polymerase chain reaction. Diagn Mol Pathol 2(3):200-9, 1993. e-Pub 1993. PMID: 8287233.
      24. Nuovo GJ, Margiotta M, MacConnell P, Becker J. Rapid in situ detection of PCR-amplified HIV-1 DNA. Diagn Mol Pathol 1(2):98-102, 1992. e-Pub 1992. PMID: 1364173.
      25. Nuovo GJ, Becker J, Margiotta M, MacConnell P, Comite S, Hochman H. Histological distribution of polymerase chain reaction--amplified human papillomavirus 6 and 11 DNA in penile lesions. Am J Surg Pathol 16(3):269-75, 1992. e-Pub 1992. PMID: 1317997.
      26. Nuovo GJ, Gallery F, MacConnell P, Becker J, Bloch W. An improved technique for the in situ detection of DNA after polymerase chain reaction amplification. Am J Pathol 139(6):1239-44, 1991. e-Pub 1991. PMID: 1661072.

      Review Articles

      1. Tanhehco YC, Alsammak M, Wu DW, Costa V, Chhibber V, Levenbrown Y, Li Y, Lu W, Mattiazzi AD, Stephens LD, Noland DK, Martin MCS, Singh N, Zantek ND, Becker J, Wehrli G. An Annual Review of Important Apheresis Articles From the American Society for Apheresis Attending Physician Subcommittee. J Clin Apher 39(6):e22152, 2024. e-Pub 2024. PMID: 39564880.
      2. Ganzel C, Becker J, Mintz PD, Lazarus HM, Rowe JM. Hyperleukocytosis, leukostasis and leukapheresis: practice management. Blood Rev 26(3):117-22, 2012. e-Pub 2012. PMID: 22364832.
      3. Becker JL. Vector-borne illnesses and the safety of the blood supply. Curr Hematol Rep 2(6):511-7, 2003. e-Pub 2003. PMID: 14561396.

      Professional Educational Materials

      1. Becker J. A review of methods Check Sample. ASCP Press, 1993.

      Editorials

      1. Becker JL. Leukapheresis: have we been looking at the right outcome?. Transfusion 53(11):2603-4, 2013. PMID: 24580647.

      Abstracts

      1. Becker J, Ailes M, Hopson A. The application of of six sigma methodologies in an outcome management program. QQPHS - Quest for Quality and Productivity in Health Services, 1999. e-Pub 1999.
      2. Becker JL. Laboratory Error Management – A practical approach for approximating perfection. QQPHS - Quest for Quality and Productivity in Health Services, 1998. e-Pub 1998.
      3. Becker J, Nuovo GJ, Miller F. The detection of EBV in renal biopsies from patients with idiopathic interstitial nephritis. ASCP/CAP 98(3):346, 1992. e-Pub 1992.
      4. Becker J, Nuovo GJ. The distribution of HPV in penile lesions as determined by PCR in-situ. ASCP/CAP 97(3):441, 1992. e-Pub 1992.
      5. Becker J, Nuovo M, Nuovo GJ, Kane P. Comparison of histologic, in situ hybridization (ISH), and polymerase chain reaction (PCR) detection of coincident viral infection in patients with pneumocystis pneumonia (PCP) and correlation with mortality. Annual Meeting of US and Canadian Academy of Pathology 5(1):115A, 1992. e-Pub 1992.
      6. Becker J, Nuovo GJ. Rapid in situ detection of PCR amplified HIV-1 DNA. Annual Meeting of US and Canadian Acad. of Pathology 5(1):43A, 1992. e-Pub 1992.
      7. Becker J, Kaplan C, Baker D. Observations on an increasing incidence of Candida funisitis. Society for Pediatric Pathology 12(2):238, 1992. e-Pub 1992.
      8. Becker J, Spitzer E. Significance of Mycobacteria seen in sputum smears in HIV infected patients. ASCP/CAP 95(2):285, 1991. e-Pub 1991.
      9. Becker J, Wheeler, AP. Impact of Platelet Transfusion on Pulmonary Function of Hematology Oncology Patients: The Piper Study. ASH.
      10. Becker J, Hopson A. Application of six sigma methodologies in health care. 4th Annual MCV Nursing and Patient Care Research Conference.
      11. Becker J, Southers M, Sabau J, Liou J, Fisher LM. Can the expiration of thawed FFP be extended?. AABB.
      12. Becker J, Ailes M. Applying a manufacturing quality system to the laboratory. AABB.
      13. Becker J, Floyd K, Posner MP, Fisher RA, Marcos A. Blood use in liver donors. AABB.
      14. Becker J, 24.Southers M. The benefits of streamlining your competency program. AABB.
      15. Becker J, Floyd K, Posner MP, Fisher RA, Marcos A. Comparison of blood use in patients receiving partial vs whole liver transplants. AABB.
      16. Becker J, Krishen P. Relationship between education and transfusion reaction reporting. AABB.
      17. Becker J, Masferrer E, Zak T. Changes in transfusion reactions reported during the change to all prestorage lukoreduction. AABB.
      18. Becker J, Boyd JC, Mintz PD. Febrile non-hemolytic transfusion reactions reported in patients receiving prestorage leukocyte-reduced or non-leukocyte-reduced red blood cells or apheresis platelets. AABB.
      19. Becker J, Boyd JC, Mintz PD. Comparison of allergic and febrile non-hemolytic transfusion reactions in recipients of leukocyte-reduced or non-leukocyte-reduced pooled whole blood-derived platelets or apheresis platelets. AABB.
      20. Becker J, Mooney C, Ford K, Gilcher R. Reduced donor procedure time with apheresis platelet collections on MDS+ LN9000 using modified software. AABB.
      21. Becker J, Myers M. Data collected from automated analysis of platelet collections: can this be used for analysis of the product?. AABB.
      22. Becker J, Benekli M, Hahn T, Hernandez L. GM-CSF mobilized donor bone marrow stem cells along with GM-CSF administration post allogeneic BMT in an attempt to reduce the incidence of GVHD – a phase II pilot study. ASH.
      23. Becker J, Ahmad I, Alam AR, Hahn T. Thalidomide plus VAD salvage for VAD-refractory multiple myeloma, prior to autologous peripheral blood stem cell transplant. ASH.
      24. Becker J, Myers M, Lorenzetti L. The use of an automated hematology analyzer to determine the white cell count in platelet collections. ASH.
      25. Becker J, Hahn T, Alam A, Miller A. Use of DLI for the treatment of relapse after allogeneic bone marrow transplantation: Effective use in chronic myeloid leukemia. ASH.
      26. Becker J, Benekli M, Hahn T, Shafi F, Qureshi A, Alam AR. The effect of Rituximab on PBSC mobilization and engraftment kinetics in non-Hodgin Lymphoma Patients. ASCO.
      27. Becker J, Lorenzetti L, Safarian D, Myers M. The use of an automated hematology analyzer to monitor leukoreduction in apheresis platelets. AABB.
      28. Becker J, McCarthy P, Sontag M, Boyd JC, Mintz P. The effect of post-thaw storage on peripheral blood stem cell (PBSC) viability. AABB.
      29. Becker J, Alam AR, Younis T, Hahn T. High dose therapy and autologous hematopoietic stem cell transplantation with an intensive VCB conditioning regimen for relapsed and refractory Hodgkin’s Disease. ASH.
      30. Becker J, Bir A, Hahn T, Miller A. Thiotepa (T) and total body irradiation vs melphalan (M) vs MT as conditioning regimen for autologous peripheral blood stem cell transplantation for multiple myeloma. ASH.
      31. Becker J, Alam AR, Varma G, Hahn T. Infectious complications in long term survivors of cord blood stem cell transplantation the experience at Roswell Park Cancer Institute. ASH.
      32. Becker J, Killion C. The effect of long term high frequency platelet conation on baseline platelet count. ASFA.
      33. Becker J, McCarthy P, Sontag M, et. al. Decreasing post thaw DMSO exposure improves peripheral blood stem cell viability. AABB.
      34. Becker J, Battiwalla M, Hahn T, Roy HN. HLA DR15 is associated with reduced incidence of acute GVHD in HLA matched allogeneic HSCT but does not impact survival. ASH.
      35. Becker J, Rodriguez E, Florczyk G, et. al. Screening donors with white blood cell counts. AABB.
      36. Becker J, Rodriguez E. Permanent donor deferrals in an established donor pool. ASFA.
      37. Becker J, Rodriguez E. Consistency of platelet yields from individual donors. ASFA.
      38. Becker J, Rodriguez E. Qualifying CBC from frequent platelet donors show consistent results. ASFA.
      39. Becker J, Turner M. Save a Life at Lunch. AABB.
      40. Becker J, Roalsvig T. Effect of TRALI policy on platelet supply. AABB.
      41. Becker J. Oncology Patients are not Immune to the Development of Red Cell Antibodies. AABB.
      42. Becker J, Patel A, Bernstein ZP, et. al.. Lack of Impact on Platelet Increments by the Number of Apheresis Platelet Units Transfused. ASH.
      43. Becker J, Lynch G, Citron J, et al. Correlation of serum free light chains with urine immunofixation free light chains in the diagnostic and follow-up of patients with intact immunoglobulin multiple myeloma in a comprehensive cancer center. AACC.
      44. Becker J, Sontag M. Transfusion reaction reporting in New York State 2001-2006. AABB.
      45. Becker J. Transfusion reaction reporting in new York State 20019-2006: Analysis by institutional size. AABB.
      46. Becker J. Variation in product use by size of transfusion service: Findings from the New York State Department of Health Blood Services Activity report. AABB.
      47. Becker J, Farrell AE. Sixty is the new fifty. Expanding the baby boomer blood base. AABB.
      48. Becker J, Rodriguez E, Duman E, Charles-Steele L. The Importance of Being Clean. ASCP.
      49. Becker J, Charles-Steele L, Rodriguez E. Putting a Face on it: Donors, Recipients, and Adherence to Procedures. AABB.
      50. Becker J. First Experiences Transfusing Platelets with Additive Solution. AABB.
      51. Becker J, Rodriguez E. Collecting Products with Platelet Additive: An Initial Experience. AABB.
      52. Becker J, Mendez B, Striejewske J. Platelet Additive Solution is Able to Provide a Product with a Predictabley Decreased Titers of Anti-A and Anti-B. AABB.
      53. Becker J, Rodriguez E, Delecki R, Secor M. Transfusion Reactions: A Reverse Lookback. AABB.
      54. Becker J, Rodriguez E. Longitudinal Analysis of Therapeutic Apheresis at a Commprehensive Cancer Center. ASFA.
      55. Becker J, Rodriguez E. Pseudothrombocytopenia in a platelet donor. ASFA.
      56. Becker J, Mendez B, Rodriguez E. Additive Solution Platelets: A Safe, Effective Product for Patients. ASCP.
      57. Becker J, Iancu D, Hutson A, Stone C, et al. Correlation between CTC counts and serum breast cancer turmor markers CA 27.29 and CEA levels and their value in time to progression prediction in the metastatic breast cancer patients under therapy. AACC.
      58. Becker J, Storch E. The evaluation of differences in platelet loss in allogeneic peripheral blood stem cell collections from 2 devices. AABB.
      59. Becker J, Scranton K. Semi-Automated Whole Blood Exchanges. ASFA.
      60. Becker J, Rodriguez E. What else is in the bag: HPC collection. ASFA.
      61. Becker J, Mendez B. Isoplate Platelets havd consistently decreased titers of Anti-A and B. AABB.
      62. Becker J. First Experiences Transfusing Platelets Produced with Isoplate. AABB.
      63. Becker J. The Incidence of Allergic Transfusion Reactions Decreases with the Use of Additive Solution Platelets. AABB.
      64. Becker J, Rodriguez E, Dalida-Gibbs C. Collecting Apheresis Platelets with Platelet Additive Solution using the Terumo Trima. ASFA.
      65. Becker J, Vesneske L, Rodriguez E. A review of autologous collections which did not meet the requested dose. ASFA.
      66. Becker J. Daratumumab Identified in Urine Immunoelectrophoresis. CAP.
      67. Becker J. Everyone on the Same Page: Communicating the Use of Monoclonal Medications to the Clinical Laboratory. CAP.
      68. Becker J, Mendez B, McCabe E, DelMonte J. The Effect of Additive Solution Platelets on the Red Cell Transfusion Rate in an Oncology Population. ASCP.
      69. Becker J, Mendez B, McCabe E, DelMonte J. The Effect of PR and PAS Platelets on Solitary Transfusion Events. AABB.
      70. Becker J, Mendez B, McCabe E, DelMonte J. The Effect of PAS and PR on Platelet Use. AABB.
      71. Becker J, Hugan S, Sherbeck JP, et al. Case Report of Six Patients Demonstrating New Unexpected Antibodies Following Treatment with PD-1/PDL-1 Blocking Antibodies. AABB.
      72. Becker J, Bat T, Wang E, et al. Feasibility of Flow Cytometric Identification and Isolation of Pre- latelets to Understand its Function and role in Cancer Metastasis. ASH.
      73. Becker J, Jerla M, Smith S, Stephenson C. Paraprotein Interference with Hamatopoietic Progenitor Cell Collection. ASFA.
      74. Becker J, Vesneske L. Patterns from a Retrospective Audit of Autologous Serum Eye Drop Manufacturing. AABB.
      75. Becker J, Mendez B. Can Other Monocloncal Medications Interfere with Antibody Screening. AABB.
      76. Becker J, Nuovo GJ. The histologic distribution of PCR-amplified HIV-1 and EBV DNA in AIDS lymphomas. Annual Meeting of US and Canadian Academy of Pathology.
      77. Becker J, Jesse JK, Tan JSG, Lehman CL. Treatment of TTP using cryopoor plasma. ASFA.
      78. Becker J, Lehman C, Yanovich S. Platelet changes in peripheral blood stem cell collections as related to mobilization regimen. AABB.
      79. Becker J, Tan J, Kinder H. Comparison of two automated methods of stem cell collection. ASH.
      80. Becker J, Alcorn K, Ripley E. Dispelling the tradition of fresh blood for transfusions in dialysis patients. ASN.
      81. Becker J, Alcorn K. Unusual presentation of TTP. ASFA.
      82. Becker J, Goel R, Pierpont DL. Is screening for platelet antibodies a reliable indicator for refractoriness. ASCP/CAP.
      83. Becker J, Sheek KJ. Saline Replacement: Rouleaux vs. Agglutination. AABB.
      84. Becker J, Tan J, Yanovich S. Mobilization and its relation to platelet recovery. AABB.
      85. Becker J, Larson A. Nursing unit review of transfusions: A useful analysis of physician practices. AABB.
      86. Becker J, Pierpont DL. Changing blood type following allogeneic bone marrow transplantation. ASCP/CAP.
      87. Becker J, Goel R, Pierpont DL. Is screening for platelet antibodies a reliable indicator for refractoriness. AABB.
      88. Becker J, Larson A, Ailes M. The importance of education in the identification and reporting of transfusion reactions. AABB.

      Book Chapters

      1. Becker J. Administration of Blood Components. AABB Press, 2010.
      2. Becker J. Administration of Blood Components. AABB Press, 597-607, 2004.
      3. Becker J, Alcom K. A manual for Clinicians. Academic Press, 333-341, 2001.
      4. Becker J. Guidelines for Blood Utilization Review. AABB Press, 2001.
      5. Nuovo GJ, Becker J. PCR Applications in Pathology. Oxford University Press, 1995.

      Books (edited and written)

      1. AABB, Becker J, Shaz B. Guidelines for Patient Blood Management and Blood Utilization. AABB Press, 2011.

      Letters to the Editor

      1. Thurer RL, Luban NL, AuBuchon JP, Silver H, McCarthy LJ, Dzik S, Stowell CP, Moore SB, Vamvakas EC, Armstrong W, Kanter MH, Jeter E, Becker J, Higgins M, Galel S, Kleinman S, Marshall CS, Newman R, Ocariz JA, Blackall D, Petz LD, Toy P, Oberman H, Siegel DL, Price TH, Slichter SJ. Universal WBC reduction. Transfusion 40: 751-2, 2000.
      Read More
      Less

      Patient Reviews


      CV information above last modified July 22, 2026

      Request an Appointment

      Whether you are ready to make an appointment now or have questions for our expert team, we are standing by to help.
      Learn more

      Related Links

      • Care Centers and Clinics

      • Departments and Divisions

      • Labs

      Clinical Trials

      Our patients have access to clinical trials offering promising new treatments that cannot be found anywhere else.
      Learn more

      Help #EndCancer

      Give Now

      Your gift will help make a tremendous difference.
      Donate

      Donate Blood

      Our patients depend on blood and platelet donations.

      Make an appointment

      Shop UT MD Anderson

      Show your support for our mission through branded merchandise.

      View products
      Subscribe to our Cancerwise newsletter
      UT MD Anderson logoUT MD Anderson logo
      • Explore
      • Patients & Family
      • Prevention & Screening
      • Donors & Volunteers
      • For Physicians
      • Research
      • Education & Training
      • Clinical Trials
      • Languages
      • About
      • About UT MD Anderson
      • Careers
      • Blog
      • Newsroom
      • Editorial Standards
      • For Employees
      • Merchandise
      • Title IX Reporting (Sexual Misconduct)
      • Price Transparency
      • Finding Your Way
      • Our Doctors
      • Locations
      • Directions
      • Sitemap
      • DIGITAL ACCESSIBILITY
      • Accessibility Policy MD Anderson works with Level Access to ensure our website is accessible and functional for all users. Free assistive technology is provided for people with physical disabilities. To learn more or to download the assistive technology tool, visit https://www.levelaccess.com/MDAnderson
      • GET IN TOUCH
      • Call
        1-877-632-6789
      • Ask a question
      • Stay Connected
      • Cancerwise Podcast
      • More
      • Website Privacy Policy
      • Legal Statement & Policies
      • Reports to the State
      • Emergency Alert Information
      • State of Texas Links
      • Our Cancer Network
      • Vendors & Suppliers
      UT MD Anderson logo
      The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

      © 2026 The University of Texas MD Anderson Cancer Center. All rights reserved.

      Top